-transparent.png){kind=logo}
We gave a regimen of cyclophosphamide and antithymocyte globulin (CY/ATG) to six patients with early stage severe aplastic anemia (SAA) transplanted with marrow from alternative donors. All patients engrafted and are alive with durable engraftment at a median follow-up of 406 days. The CY/ATG regimen may be sufficient in Korean patients with early stage SAA receiving marrow transplantation from alternative donors.
Related Publications
J H Lee, and
J H Lee, and
J S Lee, and
W K Kim, and
H S Chi, and
K H Lee
March 1995,
Blood,
J H Lee, and
J H Lee, and
J S Lee, and
W K Kim, and
H S Chi, and
K H Lee
August 1995,
Annals of hematology,
J H Lee, and
J H Lee, and
J S Lee, and
W K Kim, and
H S Chi, and
K H Lee
June 1997,
Bone marrow transplantation,
J H Lee, and
J H Lee, and
J S Lee, and
W K Kim, and
H S Chi, and
K H Lee
October 1989,
Blood,
J H Lee, and
J H Lee, and
J S Lee, and
W K Kim, and
H S Chi, and
K H Lee
January 1991,
Bone marrow transplantation,
J H Lee, and
J H Lee, and
J S Lee, and
W K Kim, and
H S Chi, and
K H Lee
June 1990,
Hematology/oncology clinics of North America,
J H Lee, and
J H Lee, and
J S Lee, and
W K Kim, and
H S Chi, and
K H Lee
February 1981,
Human immunology,
J H Lee, and
J H Lee, and
J S Lee, and
W K Kim, and
H S Chi, and
K H Lee
September 1979,
Transplantation,
J H Lee, and
J H Lee, and
J S Lee, and
W K Kim, and
H S Chi, and
K H Lee
November 1988,
Bone marrow transplantation,
J H Lee, and
J H Lee, and
J S Lee, and
W K Kim, and
H S Chi, and
K H Lee
January 1999,
Haematologica,
